CDT Equity (CDT) Prepaid Assets (2021 - 2026)
CDT Equity's (CDT) quarterly Prepaid Assets came in at $2.1 million in Q1 2026, up 132.55% YoY from $897000.0 in Q1 2025, and up 14.43% on a QoQ basis from $1.8 million in Q4 2025.
CDT Equity (CDT) Prepaid Assets (2021 - 2026) Analysis & Trends
CDT Equity (CDT) has 6 years of Prepaid Assets data on file, last reported at $2.1 million in Q1 2026.
- Quarterly Prepaid Assets rose 132.55% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 132.55% YoY) and the FY2025 annual result came in at $1.8 million, up 2.36% from the prior year.
- Prepaid Assets advanced to $2.1 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.1 million in Q1 2026 to a low of $93000.0 in Q3 2023.
- A 5-year average of $900606.8 and a median of $895000.0 in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets sank 77.77% — and 2025, when it surged 503.55%.
- Tracing CDT's Prepaid Assets over 5 years: stood at $300862.0 in 2022, then surged by 400.23% to $1.5 million in 2023, then climbed by 18.34% to $1.8 million in 2024, then grew by 2.36% to $1.8 million in 2025, then grew by 14.43% to $2.1 million in 2026.
- The last three Prepaid Assets figures came in at $2.1 million (Q1 2026), $1.8 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Mn |
| Mar 31, 2026 | 2.09 Mn |
| Dec 31, 2025 | 1.82 Mn |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 897,000.00 |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | 197,000.00 |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 198,000.00 |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 93,000.00 |
| Jun 30, 2023 | 895,000.00 |
| Mar 31, 2023 | 493,000.00 |
| Dec 31, 2022 | 300,862.00 |
| Sep 30, 2022 | 418,408.00 |
| Jun 30, 2022 | 489,023.00 |
| Mar 31, 2022 | 489,022.00 |
| Dec 31, 2021 | 55,608.00 |